Literature DB >> 823931

Treatment of Vaccinial keratitis with trifluorothymidine.

R A Hyndiuk, S Seideman, J M Leibsohn.   

Abstract

The efficacy of trifluorothymidine was compared with idoxuridine on a blind basis by noting the effect of topical administration of the drugs on the severity of vaccinial keratitis induced in rabbits. Trifluorothymidine was found to be substantially more effective, and was well tolerated. In addition, positive viral cultures after the treatment period were substantially reduced in the trifluorothymidine groups when compared with the idoxuridine or control groups.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 823931     DOI: 10.1001/archopht.1976.03910040559015

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Evaluation of therapeutic interventions for vaccinia virus keratitis.

Authors:  Sharon Altmann; Curtis R Brandt; Christopher J Murphy; Ravi Patnaikuni; Teresa Takla; Megan Toomey; Brittany Nesbit; Kimberly McIntyre; Jill Covert; Richard Dubielzig; Gary Leatherberry; Elizabeth Adkins; Shantha Kodihalli
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

2.  A quantitative rabbit model of vaccinia keratitis.

Authors:  Sharon Altmann; Andrew Emanuel; Megan Toomey; Kim McIntyre; Jill Covert; Richard Redd Dubielzig; Gary Leatherberry; Christopher J Murphy; Shantha Kodihalli; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

Review 3.  Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

4.  Effect of 5-iodo-2'-deoxyuridine on vaccinia virus (orthopoxvirus) infections in mice.

Authors:  Johan Neyts; Erik Verbeken; Erik De Clercq
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.